Black Diamond Therapeutics, Inc

Q2 2022 13F Holders

Symbol
BDTX
CUSIP
09203E105
Type
Equity
Class
COM
Num filings
80
Total reported value, excl. options
$52.9 M
Manager Report Date Value ($000) Shares Option Type